Showing 2719 results
-
In The News /Head of global nonprofit PATH explores how “social innovation” such as the Novartis Access program is helping expand access to healthcare in some of the world’s poorest countries.
-
In The News /In an editorial for Project Syndicate, Nick White, Professor of Tropical Medicine at the Mahidol Oxford Tropical Medicine Research Unit in Bangkok, and Thierry Diagana, Head of the Novartis Institute…
-
In The News /A Medium post by Steve Davis, CEO of PATH
-
In The News /The second stakeholder dialogue shared first learnings from the Kenya launch, and to continue the discussion on how to address the burden of NCDs in lower-income countries.
-
In The News /An editorial for the World Economic Forum by Harald Nusser, Head Novartis Access & Malaria Initiative
-
In The News /
-
In The News /The better we know the molecular underpinnings of a disease, the better the odds of discovering new medicines for patients. CRISPR is changing the way medicines target cancer and other diseases.
-
In The News /Healthcare expert Dr. Jonathan D. Quick discusses solutions to address the rapid rise of chronic illnesses in the developing world
-
In The News /Novartis CEO Vas Narasimhan spoke with WIRED’s Steven Levy and shared his perspective on some of the ways forward for the industry and the world.
-
In The News /